Gargoyle Investment Advisor’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$990K Sell
3,336
-500
-13% -$139K 1.53% 19
2019
Q3
$893K Buy
3,836
+1,690
+79% +$394K 1.13% 41
2019
Q2
$502K Buy
+2,146
New +$496K 0.56% 83
2018
Q3
Sell
-1,469
Closed -$426K 90
2018
Q2
$426K Hold
1,469
0.24% 86
2018
Q1
$402K Sell
1,469
-400
-21% -$124K 0.17% 113
2017
Q4
$595K Sell
1,869
-378
-17% -$121K 0.24% 100
2017
Q3
$704K Hold
2,247
0.26% 100
2017
Q2
$610K Hold
2,247
0.24% 108
2017
Q1
$615K Hold
2,247
0.24% 110
2016
Q4
$637K Hold
2,247
0.25% 107
2016
Q3
$703K Hold
2,247
0.27% 116
2016
Q2
$543K Buy
2,247
+893
+66% +$235K 0.2% 137
2016
Q1
$352K Hold
1,354
0.12% 183
2015
Q4
$415K Buy
+1,354
New +$389K 0.17% 156

Other funds holding BIIB

Gargoyle Investment Advisor's BIIB Position: Q4 2019 in Review

Gargoyle Investment Advisor reduced its Biogen (BIIB) stake by 13% in Q4 2019, selling an estimated $139K and leaving 3,336 shares worth $990K. The position accounts for 1.53% of the portfolio, ranked #19.

Gargoyle Investment Advisor first reported a position in BIIB in Q4 2015 and has held it in 14 quarters since. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Gargoyle Investment Advisor held 3,336 shares of Biogen worth $990K as of Q4 2019.
  • Gargoyle Investment Advisor sold 500 Biogen shares in Q4 2019, an estimated $139K.
  • Biogen made up 1.53% of Gargoyle Investment Advisor's portfolio in Q4 2019, its #19 holding.
  • Gargoyle Investment Advisor first reported a position in Biogen in Q4 2015 and has held it in 14 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2019, filed 18 Feb 2020.